With its excimer laser innovations, ZEISS has helped to pioneer several advancements in the area of refractive surgery as one of the world’s leading suppliers of ophthalmic solutions. Today excimer laser solutions continue to account for the majority of the corneal refractive surgery procedures. LASIK, is the most commonly performed procedure worldwide, and others such as PRK and LASEK continue to find widespread use and, to a lesser extent PTK as well.
ZEISS launched the first commercial excimer laser for clinical use in ophthalmology.
More than 20 years ago ZEISS globally introduced the first topography-guided customized treatment and shaped the field of refractive surgery with its experience and major innovations.
The MEL 90 excimer laser can intra-operatively ablate 1 diopter in as little as 1.3 seconds1 for maximum patient comfort.
The MEL® 90 from ZEISS is one of the most advanced excimer laser systems available today. It enables surgeons to flexibly choose between 250 and 500 Hz repetition rates. The MEL 90 also features the Triple-A Advanced Ablation Algorithm at either rate to achieve excellent, predictable results with minimal tissue removal.
With PRESBYOND®, ZEISS offers a software solution created especially for the presbyopic patient group – a true binocular vision correction approach. Together with the CRS-Master® and the MEL 90 from ZEISS, it allows refractive surgeons to immediately expand their LASIK repertoire.
With the remote treatment planning platform CRS-Master from ZEISS, calculating a customized Laser Vision Correction for specific types of treatment is straightforward and accurate. Results from the ZEISS CRS-Master can also be merged with the high-resolution images and precise measurements of the corneal topographer ATLAS® 9000 from ZEISS, enabling precise topography-guided treatments.